- Assistant Professor of Otolaryngology Head and Neck Surgery at CUMC
This provider accepts new patients
Appointment Phone Number: 212-305-8555
Anuraag S. Parikh, MD is a fellowship trained head and neck surgeon scientist, with clinical expertise in the full breadth of head and neck surgical oncology and microvascular reconstruction.
Dr. Parikh graduated from the Columbia University Vagelos College of Physicians & Surgeons, where he was elected to the Alpha Omega Alpha Honor Society. He completed residency in Otolaryngology-Head and Neck Surgery at Harvard University/Massachusetts Eye and Ear. During residency, he completed an additional two year postdoctoral research fellowship under an NIH T32 grant and was awarded the Jeffrey P. Harris, MD PhD Research Award for his work in tumor heterogeneity in head and neck cancer. He then completed fellowship in advanced head and neck surgical oncology and microvascular reconstruction at the Ohio State University/James Cancer Center.
Dr. Parikh’s clinical interests include the treatment of benign and malignant conditions of the head and neck, including tumors of the oral cavity, pharynx, larynx, sinonasal tract, skull base, skin, salivary glands, thyroid, and parathyroid. Dr. Parikh specializes in transoral robotic surgery (TORS) for tumors of the oropharynx and microvascular free tissue transfer for reconstruction of the head and neck.
Dr. Parikh also conducts basic and translational research aimed at understanding the role of tumor heterogeneity on treatment outcomes in head and neck cancer (HNSCC) and salivary adenoid cystic carcinoma (ACC). His work utilizes novel techniques such as single cell sequencing, multispectral imaging, and 3D organoid modeling to model HNSCC and ACC tumors at the level of individual cells. Dr. Parikh is the author of many highly impactful peer-reviewed articles, including publications in Cell and Nature Biotechnology, and he has regularly presented his research at national meetings.
Areas of Expertise
- Otolaryngology-Head & Neck Surgery
- Plastic & Reconstructive Surgery
- Cancer Reconstruction
- EarNose & Throat Surgery
- Ear Reconstruction
- Endoscopic Procedures
- External Ear Reconstruction
- Facial Reconstruction
- Free Tissue Transfers
- Head & Neck Tumors
- Head and Neck Cancer
- Head and Neck Cancer Surgery
- Jaw Reconstruction
- Larynx Cancer
- Larynx Surgery
- Laser Surgery
- Microvascular Surgery
- Minimally Invasive Procedures
- Minimally Invasive Surgery
- Minimally Invasive Techniques
- Nasal/Sinus Surgery
- Neck Surgery
- Oral Cancer
- Oral Cavity Reconstruction
- Oral Surgery
- Parathyroid Cancer
- Parathyroid Surgery
- Pharynx Surgery
- Reconstructive Facial Surgery
- Reconstructive Microsurgery
- Robotic Surgery
- Salivary Diseases
- Salivary Disorder
- Salivary Gland
- Sinus Surgery
- Skin Cancer
- Skin Cancer Surgery
- Skull Base Surgery
CUIMC/Harkness Pavilion180 Fort Washington Avenue
New York, NY 10032
- For new and current patient appointments, call:
ColumbiaDoctors - Third Avenue880 Third Avenue
New York, NY 10022
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian / Weill Cornell Medical Center
Please contact the provider's office directly to verify that your particular insurance is accepted.
- AETNA [Aetna Signature Administrators, EPO, HMO, Medicare Managed Care, NYP Employee Plan, NY Signature, POS, PPO, Student Health]
- Affinity Health Plan [Essential Plan, Medicaid Managed Care]
- AgeWell [Medicare Managed Care, Special Needs]
- Amida Care [Special Needs]
- CIGNA [EPO, Great West (National), HMO, POS, PPO]
- Emblem/GHI [Medicare Managed Care, PPO]
- Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
- Empire Blue Cross/Blue Shield [EPO, HMO, Medicare Managed Care, PPO]
- Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
- Fidelis Care [Child/Family Health Plus, Essential Plan, Medicaid Managed Care, Medicare Managed Care]
- Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]
- Oxford Health Plans [Freedom, Liberty]
- UnitedHealthcare [Compass (Exchange), Empire Plan, HMO, Medicaid (Community Plan), POS, PPO]
- VNSNY CHOICE [Medicare Managed Care, SelectHealth, Special Needs]
- WellCare [Medicaid Managed Care, Medicare Managed Care]
Li MM, Zhao S, Eskander A, Rygalski C, Brock G, Parikh AS, Haring CT, Swendseid B, Zhan KY, Bradford CR, Teknos TN, Carrau RL, VanKoevering KK, Seim NB, Old MO, Rocco JW, Puram SV, Kang SY. 2021. Stage migration and survival trends in laryngeal cancer. Annals of Surgical Oncology epub ahead of print.
Miller AL, Holcomb AJ, Parikh AS, Richards JM, Rathi VK, Goldfarb JW, Remenschneider AK, Bergmark RW, Annino DJ, Goguen LA, Rettig EM, Deschler DG, Emerick KS, Lin DT, Richmon JD, Chan CL, Min LC, Uppaluri R, Varvares MA. 2021. Assessment of preoperative functional status prior to major head and neck surgery: a pilot study. Otolaryngology-Head and Neck Surgery epub ahead of print.
Feng AL, Holcomb AJ, Abt NB, Mokhtari TE, Suresh K, McHugh CI, Parikh AS, Holman A, Kammer RE, Goldsmith TA, Faden DL, Deschler DG, Varvares MA, Lin DT, Richmon JD. 2021. Feeding tube placement following transoral robotic surgery for oropharyngeal squamous cell carcinoma. Otolaryngology-Head and Neck Surgery epub ahead of print.
Holcomb AJ, Herberg M, Strohl M, Ochoa E, Feng AL, Abt NB, Mokhtari TE, Suresh K, McHugh CI, Parikh AS, Sadow P, Faquin WC, Faden D, Deschler DG, Varvares MA, Lin DT, Fakhry C, Ryan WR, Richmon JD. 2021. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma. Head & Neck 43(8):2434-2444.
Qi Z, Liu Y, Mints M, Mullins R, Sample R, Law T, Barrett T, Mazul AL, Jackson RS, Kang SY, Pipkorn P, Parikh AS, Tirosh I, Dougherty J, Puram SV. 2021. Single-cell deconvolution of head and neck squamous cell carcinoma. Cancers (Basel) 13(6):1230.
Wu MP, Goldsmith T, Holman A, Kammer R, Parikh AS, Devore EK, Emerick KS, Lin DT, Deschler DG, Richmon JD, Varvares MA, Naunheim MR. 2021. Risk factors for laryngectomy for dysfunctional larynx after organ preservation protocols: A case-control analysis. Otolaryngology-Head and Neck Surgery 164(3):608-615.
Gadkaree SK, Parikh AS, Barbarite E, Feng AL, McCarty J, Gray ST, Lin DT. 2020. Adenoid cystic carcinoma of the skull base and nasopharynx: retrospective national cohort analysis of treatment paradigms, outcomes, and provider density. JNLS-B epub.
Parikh AS†, Shin JH†, Tirosh I, Lin DT, Sunwoo JB, Puram SV. 2020. CXCL14 inhibits xenograft tumor growth and promotes lymphocyte infiltration in immunocompetent murine models of oral cavity squamous cell carcinoma. Journal for Immunotherapy of Cancer 8:e001048.
Bulbul MG, Zenga J, Puram SV, Tarabichi O, Parikh AS, Varvares MA. 2021. Margin practices in oral cavity cancer resections: Survey of American Head and Neck Society Membership. Laryngoscope 131(4):782-787.
Lindeborg M, Sethi RKV, Puram SV, Parikh AS, Yarlagadda B, Varvares MA, Emerick KS, Lin DT, Durand M, Deschler DG. 2020. Predicting length of stay in head and neck patients who undergo free flap reconstruction. Laryngoscope Investigateive Otolaryngology 5(3):461-7.
Parikh AS, Fuller JC, Lehmann AE, Goyal N, Gray ST, Lin DT. 2019. Prognostic impact of adverse pathologic features in sinonasal squamous cell carcinoma. JNLS-B epub.
Bulbul MG, Zenga J, Puram SV, Tarabichi O, Parikh AS, Varvares MA. 2019. Understanding approaches to measurement and impact of depth of invasion in oral cavity cancers: A survey of American Head and Neck Society Membership. Oral Oncology 99.
Parikh AS, Puram SV, Faquin WC, Richmon JD, Emerick KS, Deschler DG, Varvares, MA, Tirosh I, Bernstein BE, Lin DT. 2019. Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma predicts lymph node metastasis. Oral Oncology 99.
Parikh AS, Khwaja A, Puram SV, Srikanth P, Tjoa T, Lee H, Sethi RV, Varvares MA, Rocco JW, Emerick KS, Deschler DG, Lin DT. 2019. Outcomes and prognostic factors in malignancies of the parotid gland: A 10-year single center experience. Laryngoscope Investigative Otolaryngology 4(6):632-9.
Rodarte A, Parikh AS, Gadkaree SK, Lehmann AE, Lin DT, Holbrook EH. 2019. HPV-related multiphenotypic sinonasal carcinoma: report of a case with early and progressive metastatic disease. JNLS Reports 80(4):e41-43.
Gadkaree SK†, Parikh AS†, Rodarte A, Lehmann AE, Gray ST, Lin DT. 2019. Adenoid cystic carcinoma of the skull base: response to radiation therapy and outcomes in a retrospective case series. JNLS-B..
Bulbul MG, Tarabichi O, Sethi RK, Parikh AS, Varvares MA. 2019. Does clearance of positive margins improve local control in oral cavity cancer? A meta-analysis. Otolaryngology-Head and Neck Surgery, 161(2):235-44.
Zenga J, Yu Z, Parikh, AS, Chen JX, Lin DT, Faquin WC, Varvares MA, Deschler DG. 2019. Mucoepidermoid carcinoma of the parotid: very close margins and adjuvant radiotherapy. ORL J Otorhinolaryngol Relat Spec, 81(1):55-62.
Zenga J, Parikh AS, Emerick KS, Lin DT, Faquin WC, Deschler DG. 2018. Close margins and adjuvant radiotherapy in acinic cell carcinoma of the parotid gland. JAMA Otolaryngol Head Neck Surg., E1-6.
Puram S†, Tirosh I†, Parikh AS†, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS, Deschler DG, Varvares MA, Mylvaganam R, Rozenblatt-Rosen O, Rocco JW, Faquin WC, Lin DT, Regev A, Bernstein BE. 2018. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell, 172:1-14.
Parikh AS, Bhattacharyya N. 2018. Patterns of concurrent use of cigarettes, alcohol, and e-cigarettes: off-setting or additive risk behaviors? Laryngoscope, 1-5.
Parikh AS,† Lin D, Goyal N.† 2015. Clinical outcomes of transoral robotic-assisted surgery for the management of head and neck cancer. Robotic Surgery: Research and Reviews, 2:95-105.
Munger J, Bennett BD, Parikh AS, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nature Biotechnology, 26(10):1179-86.